Injective Protocol describes itself as the first layer-2 DEX that unlocks the full potential of decentralized derivatives and borderless DeFi.

The Injective Chain is implemented as a Cosmos SDK module, built with Ethermint (EVM on Tendermint). It utilizes a Tendermint-based Proof-of-Stake to facilitate cross chain derivatives trading across Cosmos, Ethereum, and many other layer-1 protocols. In addition, the protocol is collision resistant and utilizes Verifiable Delay Functions (VDFs) to prevent front-running.

INJ is the token utilized on Injective and was launched via a public offering in 2020, becoming the first project backed by Binance Labs to debut on Binance Launchpad. The use cases intended for INJ include but are not limited to: protocol governance, exchange fee value capture, derivatives collateralization, liquidity mining, and staking.

The Injective platform enable users to take part in decentralized cross-chain derivatives trading with zero gas fees while also being able to access cross-chain yield generation for a multitude of assets. Due to how the platform is governed by a DAO structure, Injective enables everyone to create and trade on any derivative market with only a price feed, thereby opening up more opportunities for trading on markets not found on other exchanges.

Click to see more

Coin’s Details

  • Market Capitalization

    $2.32 B

  • Fully diluted valuation

    $2.39 B

  • Volume 24H

    $120.71 M

  • Circulating supply

    97 152 222

  • Total supply

    100 000 000

  • Circ. percent

    97.2%

  • All-time high

    $52.62 (-54.7%)

  • All-time high date

    Mar 14th, 2024

  • All-time low

    $0.6574 (3 527%)

  • All-time low date

    Nov 3rd, 2020

  • First announced

Injective Protocol CHART

Injective Protocol News